ARX.AX vs. SMR
ARX.AX (Aroa Biosurgery Limited) and SMR (NuScale Power Corporation) are both stocks. ARX.AX operates in Medical Devices (Healthcare), while SMR operates in Specialty Industrial Machinery (Industrials). Over the past 5 years, ARX.AX returned -9.79%/yr vs 2.96%/yr for SMR. At a 0.02 correlation, their price movements are largely independent.
Performance
ARX.AX vs. SMR - Performance Comparison
Loading charts...
Different Trading Currencies
ARX.AX is traded in AUD, while SMR is traded in USD. To make them comparable, the SMR values have been converted to AUD using the latest available exchange rates.
Returns By Period
In the year-to-date period, ARX.AX achieves a -10.81% return, which is significantly higher than SMR's -29.83% return.
ARX.AX
- 1D
- -2.22%
- 1M
- 2.33%
- YTD
- -10.81%
- 6M
- 0.00%
- 1Y
- 28.16%
- 3Y*
- -9.82%
- 5Y*
- -9.79%
- 10Y*
- —
SMR
- 1D
- -11.43%
- 1M
- -20.22%
- YTD
- -29.83%
- 6M
- -53.75%
- 1Y
- -68.79%
- 3Y*
- 7.63%
- 5Y*
- 2.96%
- 10Y*
- —
ARX.AX vs. SMR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ARX.AX Aroa Biosurgery Limited | -10.81% | -3.90% | -7.23% | -23.15% | 5.88% | -11.30% | -5.74% |
SMR NuScale Power Corporation | -29.83% | -26.71% | 499.82% | -67.91% | 9.05% | 4.92% | -1.61% |
Correlation
The correlation between ARX.AX and SMR is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Dec 10, 2020 | 0.02 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARX.AX vs. SMR — Risk / Return Rank
ARX.AX
SMR
ARX.AX vs. SMR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aroa Biosurgery Limited (ARX.AX) and NuScale Power Corporation (SMR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARX.AX | SMR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.32 | ||
| Sortino ratioReturn per unit of downside risk | +2.20 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.90 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 0.88 | -0.82 | +1.70 |
| Martin ratioReturn relative to average drawdown | 2.06 | -1.20 | +3.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARX.AX | SMR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.65 | -0.67 | +1.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.20 | 0.03 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.24 | 0.02 | -0.26 |
Drawdowns
ARX.AX vs. SMR - Drawdown Comparison
The maximum ARX.AX drawdown since its inception was -75.65%, smaller than the maximum SMR drawdown of -86.83%. Use the drawdown chart below to compare losses from any high point for ARX.AX and SMR.
Loading charts...
Drawdown Indicators
| ARX.AX | SMR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.65% | -86.83% | +11.18% |
Max Drawdown (1Y)Largest decline over 1 year | -35.85% | -84.10% | +48.25% |
Max Drawdown (3Y)Largest decline over 3 years | -60.94% | -84.10% | +23.16% |
Max Drawdown (5Y)Largest decline over 5 years | -69.88% | -86.83% | +16.95% |
Current DrawdownCurrent decline from peak | -57.14% | -81.84% | +24.70% |
Average DrawdownAverage peak-to-trough decline | -45.52% | -33.23% | -12.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.45% | 57.32% | -41.87% |
Volatility
ARX.AX vs. SMR - Volatility Comparison
The current volatility for Aroa Biosurgery Limited (ARX.AX) is 14.42%, while NuScale Power Corporation (SMR) has a volatility of 28.22%. This indicates that ARX.AX experiences smaller price fluctuations and is considered to be less risky than SMR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARX.AX | SMR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.42% | 28.22% | -13.80% |
Volatility (6M)Calculated over the trailing 6-month period | 36.83% | 67.81% | -30.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.42% | 102.36% | -52.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.99% | 91.98% | -42.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.02% | 88.09% | -40.07% |
Dividends
ARX.AX vs. SMR - Dividend Comparison
Neither ARX.AX nor SMR has paid dividends to shareholders.
Financials
ARX.AX vs. SMR - Financials Comparison
This section allows you to compare key financial metrics between Aroa Biosurgery Limited and NuScale Power Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARX.AX and SMR have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ARX.AX and SMR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer